Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Lewis

Showing results (61-70 of 225) with videos related to

Pageof 23
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2018
Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future DirectionsMichail S Lionakis, Russell E Lewis, Dimitrios P Kontoyiannis
Antimicrobial Agents and Chemotherapy|August 30, 2008
Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosisRussell E Lewis, Nathaniel D Albert, Dimitrios P Kontoyiannis
The Journal of Antimicrobial Chemotherapy|February 29, 2008
Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosisRussell E Lewis, Nathan D Albert, Dimitrios P Kontoyiannis
Medical Mycology|July 12, 2019
Beyond biomarkers: How enhanced CT imaging can improve the diagnostic-driven management of invasive mould diseaseMarta Stanzani, Claudia Sassi, Giuseppe Battista, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosisRussell E Lewis, Konstantinos Leventakos, Guangling Liao, et al.
Virulence|June 25, 2011
Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus speciesSharon C-A Chen, Russell E Lewis, Dimitrios P Kontoyiannis
The Lancet. Haematology|January 18, 2021
Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?Carlota Gudiol, Russell E Lewis, Paolo Strati, et al.
Clinical Microbiology Reviews|April 13, 2011
Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia speciesMarisa Z R Gomes, Russell E Lewis, Dimitrios P Kontoyiannis
Antimicrobial Agents and Chemotherapy|April 18, 2007
Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differencesGeorgios Chamilos, Russell E Lewis, Nathaniel Albert, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Pentamidine is active in vitro against Fusarium speciesMichail S Lionakis, Russell E Lewis, George Samonis, et al.
Pageof 23

Showing results (61-70 of 225) with videos related to

Sort By:
Pageof 23
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2018
Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future DirectionsMichail S Lionakis, Russell E Lewis, Dimitrios P Kontoyiannis
Antimicrobial Agents and Chemotherapy|August 30, 2008
Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosisRussell E Lewis, Nathaniel D Albert, Dimitrios P Kontoyiannis
The Journal of Antimicrobial Chemotherapy|February 29, 2008
Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosisRussell E Lewis, Nathan D Albert, Dimitrios P Kontoyiannis
Medical Mycology|July 12, 2019
Beyond biomarkers: How enhanced CT imaging can improve the diagnostic-driven management of invasive mould diseaseMarta Stanzani, Claudia Sassi, Giuseppe Battista, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2011
Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosisRussell E Lewis, Konstantinos Leventakos, Guangling Liao, et al.
Virulence|June 25, 2011
Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus speciesSharon C-A Chen, Russell E Lewis, Dimitrios P Kontoyiannis
The Lancet. Haematology|January 18, 2021
Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?Carlota Gudiol, Russell E Lewis, Paolo Strati, et al.
Clinical Microbiology Reviews|April 13, 2011
Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia speciesMarisa Z R Gomes, Russell E Lewis, Dimitrios P Kontoyiannis
Antimicrobial Agents and Chemotherapy|April 18, 2007
Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differencesGeorgios Chamilos, Russell E Lewis, Nathaniel Albert, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
Pentamidine is active in vitro against Fusarium speciesMichail S Lionakis, Russell E Lewis, George Samonis, et al.
Pageof 23